EP 2812355 A4 20160302 - COMPOSITIONS AND METHODS FOR USING CSF1R INHIBITORS
Title (en)
COMPOSITIONS AND METHODS FOR USING CSF1R INHIBITORS
Title (de)
ZUSAMMENSETZUNGEN UND VERFAHREN ZUR VERWENDUNG VON CSF1R-INHIBITOREN
Title (fr)
COMPOSITIONS ET PROCÉDÉS D'UTILISATION D'INHIBITEURS DE CSF1R
Publication
Application
Priority
- US 201261595658 P 20120206
- US 201261680674 P 20120807
- US 2013024998 W 20130206
Abstract (en)
[origin: WO2013119716A1] The invention provides CSF1-R pathway inhibitors, including anti-IL-34 antibodies, bispecific anti-IL-34/CSF-1 antibodies and anti-CSF-1R antibodies and methods of using the same for treating myeloid pathogenic immunological diseases.
IPC 8 full level
C07K 16/24 (2006.01); A61K 39/395 (2006.01); A61P 19/02 (2006.01)
CPC (source: EP)
A61P 1/04 (2017.12); A61P 19/02 (2017.12); A61P 25/00 (2017.12); A61P 29/00 (2017.12); A61P 37/06 (2017.12); C07K 14/54 (2013.01); C07K 14/7153 (2013.01); C07K 16/243 (2013.01); C07K 16/244 (2013.01); A61K 2039/505 (2013.01); A61K 2039/507 (2013.01); C07K 2317/21 (2013.01); C07K 2317/55 (2013.01); C07K 2317/56 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01); Y02A 50/30 (2017.12)
Citation (search report)
- [I] WO 2011140249 A2 20111110 - FIVE PRIME THERAPEUTICS INC, et al
- [I] WO 2009112245 A1 20090917 - TRANSGENE SA [FR], et al
- [IA] HAISHAN LIN ET AL: "Discovery of a cytokine and its receptor by functional screening of the extracellular proteome", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE, US, vol. 320, no. 5877, 9 May 2008 (2008-05-09), pages 807 - 811, XP002638423, ISSN: 1095-9203, DOI: 10.1126/SCIENCE.1154370
- [A] DROIN NATHALIE ET AL: "Editorial: CSF1R, CSF-1, and IL-34, a menage a trois conserved across vertebrates", JOURNAL OF LEUKOCYTE BIOLOGY, FEDERATION OF AMERICAN SOCIETIES FOR EXPERIMENTAL BIOLOGY, US, vol. 87, no. 5, 1 May 2010 (2010-05-01), pages 745 - 747, XP009138538, ISSN: 0741-5400, DOI: 10.1189/JLB.1209780
- [A] T CHIHARA ET AL: "IL-34 and M-CSF share the receptor Fms but are not identical in biological activity and signal activation", CELL DEATH AND DIFFERENTIATION, vol. 17, no. 12, 1 December 2010 (2010-12-01), pages 1917 - 1927, XP055036155, ISSN: 1350-9047, DOI: 10.1038/cdd.2010.60
- See references of WO 2013119716A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2013119716 A1 20130815; WO 2013119716 A8 20140807; BR 112014018961 A2 20170620; BR 112014018961 A8 20170711; CA 2861122 A1 20130815; CN 104093740 A 20141008; CN 104093740 B 20180109; EP 2812355 A1 20141217; EP 2812355 A4 20160302; HK 1202879 A1 20151009; JP 2015510510 A 20150409; JP 2017200482 A 20171109; JP 6416630 B2 20181031; KR 20140127855 A 20141104; MX 2014008961 A 20141014; RU 2014136332 A 20160327
DOCDB simple family (application)
US 2013024998 W 20130206; BR 112014018961 A 20130206; CA 2861122 A 20130206; CN 201380008292 A 20130206; EP 13746304 A 20130206; HK 15103325 A 20150401; JP 2014555859 A 20130206; JP 2017116326 A 20170613; KR 20147024752 A 20130206; MX 2014008961 A 20130206; RU 2014136332 A 20130206